Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine
(Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that the Company was named the leading Proteomics Solutions Company in the U.S. by Life Sciences Review Magazine , featured in the December 2022 issue, Top 10 Proteomics Solutions Companies of 2022.
- (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that the Company was named the leading Proteomics Solutions Company in the U.S. by Life Sciences Review Magazine , featured in the December 2022 issue, Top 10 Proteomics Solutions Companies of 2022.
- Biodesix is a market leader with over 15 years of experience in the field of clinical proteomics.
- The Top 10 Proteomics Solutions Companies digital issue is now available at LifeSciencesReview.com, and the full Biodesix profile can be found at www.lifesciencesreview.com/biodesix-inc .
- Biodesix is a leading data-driven diagnostic solutions company with a focus in lung disease.